Systematic review of stereotactic radiotherapy for high-grade gliomas;Radiothrapie en conditions strotaxiques des gliomes de haut grade : une revue de la littrature

Cancer/Radiotherapie

Volumn 14, Issue 8, 2010, Pages 739-754

  Clavier, J B ^a   Voirin, J ^b   Kehrli, P ^b   Noel G ^a  

^a CENTRE PAUL STRAUSS   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Evidence based medicine; Glioma; Radiosurgery; Stereotactic fractionated radiation therapy

Indexed keywords

CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; DATA BASE; GLIOMA; HIGH GRADE GLIOMA; HUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SHORT SURVEY; STEREOTACTIC RADIOSURGERY; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGE; AGED; BRAIN TUMOR; CHILD; CLINICAL TRIAL (TOPIC); EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FEMALE; GLIOBLASTOMA; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURY; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURIES; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649634088     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.03.021     Document Type: Short Survey

References (81)

1. Alexander E., Loeffler J.S. Radiosurgery using a modified linear accelerator. Neurosurg Clin N Am 1992, 3:167-190.
2. Bauman G.S., Sneed P.K., Wara W.M., Stalpers L.J., Chang S.M., McDermott M.W., et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 1996, 36:433-441.
3. Baumert B.G., Lutterbach J., Bernays R., Davis J.B., Heppner F.L. Fractionated stereotactic radiotherapy boost after postoperative radiotherapy in patients with high-grade gliomas. Radiother Oncol 2003, 67:183-190.
4. Baumert B.G., Brada M., Bernier J., Kortmann R.D., Dehing-Oberije C., Collette L., et al. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm. Radiother Oncol 2008, 88:163-172.
5. Bhatnagar A., Heron D.E., Kondziolka D., Lunsford L.D., Flickinger J.C. Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors. Int J Radiat Oncol Biol Phys 2002, 53:527-532.
6. Bleehen N.M., Girling D.J., Gregor A., Leonard R.C., Machin D., McKenzie C.G., et al. A medical research council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. Br J Cancer 1991, 64:775-779.
7. Brada M., Baumert B. Focal fractionated conformal stereotactic boost following conventional radiotherapy of high-grade gliomas: a randomized phase III study. A joint study of the EORTC (22972) and the MRC (BR10). Front Radiat Ther Oncol 1999, 33:241-243.
8. Brem H., Piantadosi S., Burger P.C., Walker M., Selker R., Vick N.A., et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345:1008-1012.
9. Buatti J.M., Friedman W.A., Bova F.J., Mendenhall W.M. Linac radiosurgery for high-grade gliomas: the University of Florida experience. Int J Radiat Oncol Biol Phys 1995, 32:205-210.
10. Cardinale R.M., Schmidt-Ullrich R.K., Benedict S.H., Zwicker R.D., Han D.C., Broaddus W.C. Accelerated radiotherapy regimen for malignant gliomas using stereotactic concomitant boosts for dose escalation. Radiat Oncol Investig 1998, 6:175-181.
11. Cardinale R., Won M., Choucair A., Gillin M., Chakravarti A., Schultz C., et al. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys 2006, 65:1422-1428.
12. Chamberlain M.C., Barba D., Kormanik P., Shea W.M. Stereotactic radiosurgery for recurrent gliomas. Cancer 1994, 74:1342-1347.
13. Chinot O.L., Honore S., Dufour H., Barrie M., Figarella-Branger D., Muracciole X., et al. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. J Clin Oncol 2001, 19:2449-2455.
14. Cho K.H., Hall W.A., Gerbi B.J., Higgins P.D., McGuire W.A., Clark H.B. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 1999, 45:1133-1141.
15. Combs S.E., Thilmann C., Edler L., Debus J., Schulz-Ertner D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 2005, 23:8863-8869.
16. Coughlin C., Scott C., Langer C., Coia L., Curran W., Rubin P. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (>20 or ≤20cm [2], respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. Int J Radiat Oncol Biol Phys 2000, 48:1351-1358.
17. Curran W.J., Scott C.B., Horton J., Nelson J.S., Weinstein A.S., Fischbach A.J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993, 85:704-710.
18. Curran W.J., Scott C.B., Weinstein A.S., Martin L.A., Nelson J.S., Phillips T.L., et al. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 1993, 11:857-862.
19. Daumas-Duport C., Blond S., Vedrenne C., Szikla G. Radiolesion versus recurrence: bioptic data in 39 gliomas after interstitial and external radiation treatment. Acta Neurochir Suppl (Wien) 1984, 33:291-299.
20. Deutsch M., Green S.B., Strike T.A., Burger P.C., Robertson J.T., Selker R.G., et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole, plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989, 16:1389-1396.
21. Dirks P., Bernstein M., Muller P.J., Tucker W.S. The value of reoperation for recurrent glioblastoma. Can J Surg 1993, 36:271-275.
22. Ernst-Stecken A., Ganslandt O., Lambrecht U., Sauer R., Grabenbauer G. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 2007, 81:287-294.
23. Fitzek M.M., Thornton A.F., Rabinov J.D., Lev M.H., Pardo F.S., Munzenrider J.E., et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1999, 91:251-260.
24. Fokas E., Wacker U., Gross M.W., Henzel M., Encheva E., Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy?. Strahlenther Onkol 2009, 185:235-240.
25. Fulton D.S., Urtasun R.C., Scott-Brown I., Johnson E.S., Mielke B., Curry B., et al. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study. J Neurooncol 1992, 14:63-72.
26. Gannett D., Stea B., Lulu B., Adair T., Verdi C., Hamilton A. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 1995, 33:461-468.
27. Glass J., Silverman C.L., Axelrod R., Corn B.W., Andrews D.W. Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 1997, 20:226-229.
28. Grosu A.L., Weber W.A., Franz M., Stark S., Piert M., Thamm R., et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:511-519.
29. Guiu S., Taillibert S., Chinot O., Taillandier L., Honnorat J., Dietrich P.Y., et al. Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants: résultats préliminaires d'une étude multicentrique de l'Anocef. Rev Neurol (Paris) 2008, 164:588-594.
30. Gutin P.H., Iwamoto F.M., Beal K., Mohile N.A., Karimi S., Hou B.L., et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2009, 75:156-163.
31. Hall W.A., Djalilian H.R., Sperduto P.W., Cho K.H., Gerbi B.J., Gibbons J.P., et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 1995, 13:1642-1648.
32. Harsh G.R.t., Levin V.A., Gutin P.H., Seager M., Silver P., Wilson C.B. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987, 21:615-621.
33. Hess C.F., Schaaf J.C., Kortmann R.D., Schabet M., Bamberg M. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994, 30:146-149.
34. Hudes R.S., Corn B.W., Werner-Wasik M., Andrews D., Rosenstock J., Thoron L., et al. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 1999, 43:293-298.
35. Irish W.D., Macdonald D.R., Cairncross J.G. Measuring bias in uncontrolled brain tumor trials to randomize or not to randomize?. Can J Neurol Sci 1997, 24:307-312.
36. Keime-Guibert F., Chinot O., Taillandier L., Cartalat-Carel S., Frenay M., Kantor G., et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007, 356:1527-1535.
37. Kohshi K., Yamamoto H., Nakahara A., Katoh T., Takagi M. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol 2007, 82:297-303.
38. Kondziolka D., Flickinger J.C., Bissonette D.J., Bozik M., Lunsford L.D. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997, 41:776-783. [discussion 83-5].
39. Laing R.W., Warrington A.P., Graham J., Britton J., Hines F., Brada M. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother Oncol 1993, 27:22-29.
40. Landy H., Markoe A., Potter P., Lasalle G., Marini A., Savaraj N., et al. Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma. J Neurooncol 2004, 67:215-220.
41. Langer C.J., Ruffer J., Rhodes H., Paulus R., Murray K., Movsas B., et al. Phase II Radiation Therapy Oncology Group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001, 51:113-119.
42. Larson D.A., Gutin P.H., McDermott M., Lamborn K., Sneed P.K., Wara W.M., et al. Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 1996, 36:1045-1053.
43. Larson D.A., Prados M., Lamborn K.R., Smith V., Sneed P.K., Chang S., et al. Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys 2002, 54:1397-1404.
44. Lederman G., Arbit E., Odaimi M., Lombardi E., Wrzolek M., Wronski M. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. Int J Radiat Oncol Biol Phys 1998, 40:661-666.
45. Lederman G., Wronski M., Arbit E., Odaimi M., Wertheim S., Lombardi E., et al. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 2000, 23:155-159.
46. Lemaire J.J., Khalil T., Bard J.J., Verrelle P. Place de la radiochirurgie dans le traitement des oligodendrogliomes. Neurochirurgie 2005, 51:393-399.
47. Loeffler J.S., Alexander E., Shea W.M., Wen P.Y., Fine H.A., Kooy H.M., et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992, 10:1379-1385.
48. Lustig R.A., Scott C.B., Curran W.J. Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?. Am J Clin Oncol 2004, 27:516-521.
49. Marin L.A., Smith C.E., Langston M.Y., Quashie D., Dillehay L.E. Response of glioblastoma cell lines to low dose rate irradiation. Int J Radiat Oncol Biol Phys 1991, 21:397-402.
50. Masciopinto J.E., Levin A.B., Mehta M.P., Rhode B.S. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 1995, 82:530-535.
51. Mehta M.P., Masciopinto J., Rozental J., Levin A., Chappell R., Bastin K., et al. Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 1994, 30:541-549.
52. Nieder C., Andratschke N., Wiedenmann N., Busch R., Grosu A.L., Molls M. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?. Strahlenther Onkol 2004, 180:401-407.
53. Noël G., Ben Ammar C.N., Feuvret L., Valery C.A., Cornu P., Boisserie G., et al. Résultats de l'irradiation en conditions stéréotaxiques de rattrapage de 14 patients atteints d'un gliome de grade III ou IV. Rev Neurol (Paris) 2004, 160:539-545.
54. Nwokedi E.C., DiBiase S.J., Jabbour S., Herman J., Amin P., Chin L.S. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 2002, 50:41-46. [discussion 6-7].
55. Park J.L., Suh J.H., Barnett G.H., Reddy C.A., Peereboom D.M., Stevens G.H.J., et al. Survival after stereotactic radiosurgery for recurrent glioblastoma multiforme. J Radiosurg 2000, 3:169-175.
56. Patel M., Siddiqui F., Jin J.Y., Mikkelsen T., Rosenblum M., Movsas B., et al. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 2009, 92:185-191.
57. Prisco F.E., Weltman E., Hanriot R.M., Brandt R.A. Radiosurgical boost for primary high-grade gliomas. J Neurooncol 2002, 57:151-160.
58. Raaphorst G.P., Feeley M.M., Da Silva V.F., Danjoux C.E., Gerig L.H. A comparison of heat and radiation sensitivity of three human glioma cell lines. Int J Radiat Oncol Biol Phys 1989, 17:615-622.
59. Raza S.M., Lang F.F., Aggarwal B.B., Fuller G.N., Wildrick D.M., Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery 2002, 51:2-12. [discussion: 3].
60. Regine W.F., Patchell R.A., Strottmann J.M., Meigooni A., Sanders M., Young B. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. J Neurosurg 2000, 93:37-41.
61. Sarkaria J.N., Mehta M.P., Loeffler J.S., Buatti J.M., Chappell R.J., Levin A.B., et al. Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1995, 32:931-941.
62. Schwer A.L., Damek D.M., Kavanagh B.D., Gaspar L.E., Lillehei K., Stuhr K., et al. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2008, 70:993-1001.
63. Selch M.T., DeSalles A.A.F., Solberg T.D., Wallace R.E., Do T.M., Ford J., et al. Hypofractionated sterotactic radioterapy for recurrent malignant glioma. J Radiosurg 2000, 3:3-12.
64. Shenouda G., Souhami L., Podgorsak E.B., Bahary J.P., Villemure J.G., Caron J.L., et al. Radiosurgery and accelerated radiotherapy for patients with glioblastoma. Can J Neurol Sci 1997, 24:110-115.
65. Shepherd S.F., Laing R.W., Cosgrove V.P., Warrington A.P., Hines F., Ashley S.E., et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997, 37:393-398.
66. Shrieve D.C., Alexander E., Black P.M., Wen P.Y., Fine H.A., Kooy H.M., et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 1999, 90:72-77.
67. Shrieve D.C., Alexander E., Wen P.Y., Fine H.A., Kooy H.M., Black P.M., et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 1995, 36:275-282. [discussion 82-4].
68. Simon J.M., Cornu P., Boisserie G., Hasboun D., Tep B., Hardiman C., et al. Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume. Int J Radiat Oncol Biol Phys 2002, 53:67-74.
69. Souhami L., Seiferheld W., Brachman D., Podgorsak E.B., Werner-Wasik M., Lustig R., et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004, 60:853-860.
70. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
71. Szeifert G.T., Prasad D., Kamyrio T., Steiner M., Steiner L.E. The role of the Gamma Knife in the management of cerebral astrocytomas. In radiosurgery and pathological fundamentals. Prog Neurol Surg Basel Karger 2007, 20:150-163.
72. Tsao M.N., Mehta M.P., Whelan T.J., Morris D.E., Hayman J.A., Flickinger J.C., et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 2005, 63:47-55.
73. Ulm A.J., Friedman W.A., Bradshaw P., Foote K.D., Bova F.J. Radiosurgery in the treatment of malignant gliomas: the University of Florida experience. Neurosurgery 2005, 57:512-517. [discussion: 7].
74. van Kampen M., Engenhart-Cabillic R., Debus J., Fuss M., Rhein B., Wannenmacher M. The radiosurgery of glioblastoma multiforme in cases of recurrence. The Heidelberg experiences compared to the literature. Strahlenther Onkol 1998, 174:19-24.
75. Veninga T., Langendijk H.A., Slotman B.J., Rutten E.H., van der Kogel A.J., Prick M.J., et al. Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 2001, 59:127-137.
76. Vordermark D., Kolbl O., Ruprecht K., Vince G.H., Bratengeier K., Flentje M. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer 2005, 5:55.
77. Voynov G., Kaufman S., Hong T., Pinkerton A., Simon R., Dowsett R. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 2002, 25:606-611.
78. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979, 5:1725-1731.
79. Westphal M., Ram Z., Riddle V., Hilt D., Bortey E. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 2006, 148:269-275. [discussion 75].
80. Wong E.T., Hess K.R., Gleason M.J., Jaeckle K.A., Kyritsis A.P., Prados M.D., et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 1999, 17:2572-2578.
81. Wurm R.E., Kuczer D.A., Schlenger L., Matnjani G., Scheffler D., Cosgrove V.P., et al. Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma. Int J Radiat Oncol Biol Phys 2006, 66:S26-S32.